New-generation technology
SpectraCure has developed an innovative, world-leading technology dedicated to interstitial PDT - The SpectraCure PDT System with IDOSE® - enabling precise, safe and accurate photodynamic therapy.
The SpectraCure product portfolio consists of:
The SpectraCure product portfolio consists of:
SpectraCure PDT System which delivers the therapeutic light that is monitored in real time, via up to 18 individual fibrers.
Sophisticated software IDOSE® that performs predosimetry planning and the light dosimetry updates during the treatment.
The SpectraCure PDT System with IDOSE® is dedicated to interstitial PDT and was developed by the researchers and scientists at the Atomic Physics Division and at the Lund University Medical Laser Centre.
Advancing cancer treatment with IDOSE®
